Hubei Klavi Biopharm Co., Ltd. is a high-tech enterprise engaged in R&D, manufacturing, marketing and sales of intermediates & APIs derived from fermentation and chemical synthesis, especially in the field of ergot derivatives. We have our own GMP facility, 9 production units, with over 500 mt fermentation capacity (to be expanded to 1000 mt) to produce our featured products: Nicergoline; Dihydroergotoxine; Methylergonovine Maleate (MEM); Bromocriptine; Cabergoline; Fusidic Acid; Sodium Fusidate; Pimecrolimus; Josamycin, Polymyxin B Sulfate and Vitamin K2.
Year Established: 2019
Total Number of Staff: 100-500
Main Competitive Advantages: Experienced R&D Staff,Production Capacity,Contract Manufacturing (CRO,CMO),Quality Service
Business Type: Manufacturer
R&D Capacity: Own Brand
Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Subscribe to the latest newsletter of Virtual Expo Connect
Josamycin
Sodium Fusidate
Fusidic Acid
Demeclocycline Hydrochloride